Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Ekdahl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2014
Systemic exposure to the metabolites of lesogaberan in humans and animals: a case study of metabolites in safety testingAnn Aurell Holmberg, Anja Ekdahl, Lars Weidolf
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 4, 2012
Identification of the metabolites of lesogaberan using linear trap quadrupole orbitrap mass spectrometry and hydrophilic interaction liquid chromatographyAnja Ekdahl, Ann Aurell-Holmberg, Neal Castagnoli
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 19, 2013
Tracing and separating plasma components causing matrix effects in hydrophilic interaction chromatography-electrospray ionization mass spectrometryAnja Ekdahl, Maria C Johansson, Martin Ahnoff
Bioanalysis|February 21, 2015
Matrix effect explained by unexpected formation of peptide in acidified plasmaMartin Ahnoff, Ann-Christin Nyström, Fritz Schweikart, et al.
Archives of Toxicology|August 11, 2018
The metabolic fate of fenclozic acid in chimeric mice with a humanized liverAnja Ekdahl, Lars Weidolf, Matthew Baginski, et al.
International Journal of Molecular Sciences|February 13, 2025
Investigation of Biotransformation Pathways in a Chimeric Mouse with a Humanized LiverIsabella B Karlsson, Anja Ekdahl, Hugh Etchingham-Coll, et al.
Molecular Pharmaceutics|October 14, 2025
Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend AnalysisMarie Ahlqvist, Isabella Bonner Karlsson, Anja Ekdahl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2023
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, et al.
Molecular Pharmaceutics|October 2, 2013
Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitorElin M Matsson, Ulf G Eriksson, Johan E Palm, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2014
Systemic exposure to the metabolites of lesogaberan in humans and animals: a case study of metabolites in safety testingAnn Aurell Holmberg, Anja Ekdahl, Lars Weidolf
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 4, 2012
Identification of the metabolites of lesogaberan using linear trap quadrupole orbitrap mass spectrometry and hydrophilic interaction liquid chromatographyAnja Ekdahl, Ann Aurell-Holmberg, Neal Castagnoli
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 19, 2013
Tracing and separating plasma components causing matrix effects in hydrophilic interaction chromatography-electrospray ionization mass spectrometryAnja Ekdahl, Maria C Johansson, Martin Ahnoff
Bioanalysis|February 21, 2015
Matrix effect explained by unexpected formation of peptide in acidified plasmaMartin Ahnoff, Ann-Christin Nyström, Fritz Schweikart, et al.
Archives of Toxicology|August 11, 2018
The metabolic fate of fenclozic acid in chimeric mice with a humanized liverAnja Ekdahl, Lars Weidolf, Matthew Baginski, et al.
International Journal of Molecular Sciences|February 13, 2025
Investigation of Biotransformation Pathways in a Chimeric Mouse with a Humanized LiverIsabella B Karlsson, Anja Ekdahl, Hugh Etchingham-Coll, et al.
Molecular Pharmaceutics|October 14, 2025
Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend AnalysisMarie Ahlqvist, Isabella Bonner Karlsson, Anja Ekdahl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2023
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, et al.
Molecular Pharmaceutics|October 2, 2013
Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitorElin M Matsson, Ulf G Eriksson, Johan E Palm, et al.
Pageof 1